Common Contracts
5 similar null contracts by Dermata Therapeutics, Inc., Guardforce AI Co., LTD, Iveda Solutions, Inc., others
Mr. Wangfeng Yan Chief Executive Officer Tantech Holdings Ltd.Tantech Holdings LTD • April 26th, 2024 • Industrial organic chemicals • New York
This letter (the “Agreement”) constitutes the agreement between Maxim Group LLC (“Maxim” or the “Placement Agent”) and Tantech Holdings Ltd., a British Virgin Islands company (the “Company”), that Maxim shall serve as the exclusive placement agent for the Company, on a “reasonable best efforts” basis, in connection with the proposed private placement (the “Placement”) of shares (the “Shares”) of the Company’s common shares, par value $0.24 (the “Common Stock”), pre-funded warrants to purchase Common Stock (the “Pre-Funded Warrants”), Series A warrants to purchase Common Stock (the “Series A Warrants”) and Series B warrants to purchase Common Stock (the “Series B Warrants”, collectively with the Series A Warrants, the “Common Warrants”, collectively with the Pre-Funded Warrants, the “Warrants,” and the shares issuable upon exercise of the Warrants, the “Warrant Shares” and the Shares, Warrants and Warrant Shares, collectively, the “Securities”). The terms of the Placement shall be mutua
Mr. Gareth Genner Chief Executive Officer T Stamp Inc.T Stamp Inc • April 4th, 2024 • Services-prepackaged software • New York
Mr. David Ly Chief Executive Officer and Chairman Iveda Solutions, Inc.Iveda Solutions, Inc. • August 12th, 2022 • Services-prepackaged software • New York
Mr. Gerald Proehl President and Chief Executive Officer Dermata Therapeutics, Inc.Dermata Therapeutics, Inc. • April 25th, 2022 • Pharmaceutical preparations • New York
Guardforce AI Co., LimitedGuardforce AI Co., LTD • January 21st, 2022 • Services-detective, guard & armored car services • New York
